Matches in Nanopublications for { ?s ?p "[Promoter hypermethylation of MGMT is commonly used to predict low expression levels of MGMT in gliomas, despite observed discordance between promoter methylation and protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Promoter hypermethylation of MGMT is commonly used to predict low expression levels of MGMT in gliomas, despite observed discordance between promoter methylation and protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP555256.RAweCuAjqF3pQGMsFVGXQSyf7TnbV5ENW_ETFKs70RJ5M130_assertion description "[Promoter hypermethylation of MGMT is commonly used to predict low expression levels of MGMT in gliomas, despite observed discordance between promoter methylation and protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555256.RAweCuAjqF3pQGMsFVGXQSyf7TnbV5ENW_ETFKs70RJ5M130_provenance.
- NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_assertion description "[Promoter hypermethylation of MGMT is commonly used to predict low expression levels of MGMT in gliomas, despite observed discordance between promoter methylation and protein levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158027.RAHfARWacBn3n6NDYOY6G5quJ9Y-QbvZagHcv9Myj7Clg130_provenance.